Navigation path


Diagnostics and Surveillance

Rapid, robust & scalable platform technology for fully automated reference laboratory grade Polymerase Chain Reaction (PCR) based diagnostics regardless of global setting.

EC contribution
: € 2,982,200
: 24 months
Starting date
: 01/07/2008
Funding scheme
: Collaborative project - Small- or medium-scale focused research project targeted to SMEs
: ranger, influenza, diagnostics, PCR, molecular, point of care, surveillance, rapid, automated, real-time
Contract/Grant agreement number
: 201569
Project web-site


The RANGER consortium brings together clinical and technical to deliver a system capable of diagnosing influenza accurately and quickly, enabling healthcare professionals and outbreak specialists to make timely and informed decisions.

The system will be fully automated and capable of providing a laboratory standard result from a raw sample. Prototype instruments, cartridges and assays will be developed and validated for use as human in vitro diagnostics for influenza diagnosis and surveillance, offering:

  • Rapid diagnosis of influenza (both seasonal and pandemic) in the point-of-care environment, enabling faster and better informed medical care to reduce suffering and save lives.
  • Co-ordinated surveillance of influenza incidents and outbreaks, enabling rapid deployment of resources to control disease spread and treat patients.


Influenza is one of today's biggest threats to the world's socio-economic health. Seasonal, or epidemic influenza, has a global incidence of 10-20%, is responsible for between 3 and 5 million cases of severe illness every year and causes 500,000 deaths annually. Total direct and indirect costs of a severe epidemic are estimated at over $12 billion in the US alone.

[+] Read More